Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity

Claudio Letizia, Gianluca Iacobellis, C. Caliumi, F. Leonetti, D. Cotesta, M. C. Ribaudo, L. Petramala, R. Cianci, M. Celi, E. D'Erasruio, U. Di Mario

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: Adrenomedullin (AM) is a potent hypotensive peptide which may be implicated in the insulin regulatory system. Acute hyperinsulinemia exerts no influence on plasma AM in normal subjects while no data on obese subjects has been reported. Purpose: The aim of the study was to investigate the effect of acute hyperinsulinemia on the plasma AM concentration in patients with uncomplicated obesity. Research Methods: We measured the plasma AM levels in 23 obese subjects (BMI 41.9 ± 9.8 kg/m2), 21 females and 2 males (mean age 31 ± 7.2 years), before and during a euglycemic hyperinsulinemic clamp. The control group consisted of 43 healthy subjects (HS) (22 males and 21 females; mean age 38 ± 12 years; BMI 23.3 ± 3.2 kg/m2). Results: Baseline plasma AM was found to be higher in obese subjects (20.4 ± 8.4 pg/ml) than in normal subjects (11.3 ± 0.8 pg/ml) (p < 0.001). A significant increase in the plasma AM levels was observed in obese subjects during acute hyperinsulinemia (from 20.4 ± 8.4 pg/ml at 0 min to 26 ± 8.9 pg/ml at 120 min, p < 0.02). Plasma AM concentrations were significantly correlated with insulin levels at 30 min (r = 0.44; p = 0.04) and 120 min (r = 0.40, p = 0.05) during the clamp. Discussion: In conclusion, acute hyperinsulinemia induced a significant increase in the plasma levels of AM in uncomplicated obese subjects. Hyperinsulinemia may, at least in part, regulate levels of AM in obesity, explaining the high levels of the peptide in these subjects.

Original languageEnglish
Pages (from-to)171-175
Number of pages5
JournalExperimental and Clinical Endocrinology and Diabetes
Volume113
Issue number3
DOIs
StatePublished - Mar 1 2005
Externally publishedYes

Fingerprint

Adrenomedullin
Hyperinsulinism
Obesity
Insulin
Peptides
Glucose Clamp Technique
Healthy Volunteers
Control Groups

Keywords

  • Adrenomedullin
  • Euglycemic hyperinsulinemic clamp

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity. / Letizia, Claudio; Iacobellis, Gianluca; Caliumi, C.; Leonetti, F.; Cotesta, D.; Ribaudo, M. C.; Petramala, L.; Cianci, R.; Celi, M.; D'Erasruio, E.; Di Mario, U.

In: Experimental and Clinical Endocrinology and Diabetes, Vol. 113, No. 3, 01.03.2005, p. 171-175.

Research output: Contribution to journalArticle

Letizia, C, Iacobellis, G, Caliumi, C, Leonetti, F, Cotesta, D, Ribaudo, MC, Petramala, L, Cianci, R, Celi, M, D'Erasruio, E & Di Mario, U 2005, 'Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity', Experimental and Clinical Endocrinology and Diabetes, vol. 113, no. 3, pp. 171-175. https://doi.org/10.1055/s-2005-837519
Letizia, Claudio ; Iacobellis, Gianluca ; Caliumi, C. ; Leonetti, F. ; Cotesta, D. ; Ribaudo, M. C. ; Petramala, L. ; Cianci, R. ; Celi, M. ; D'Erasruio, E. ; Di Mario, U. / Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity. In: Experimental and Clinical Endocrinology and Diabetes. 2005 ; Vol. 113, No. 3. pp. 171-175.
@article{dfe15a55b4714b6b8f4f6e667daafb89,
title = "Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity",
abstract = "Objective: Adrenomedullin (AM) is a potent hypotensive peptide which may be implicated in the insulin regulatory system. Acute hyperinsulinemia exerts no influence on plasma AM in normal subjects while no data on obese subjects has been reported. Purpose: The aim of the study was to investigate the effect of acute hyperinsulinemia on the plasma AM concentration in patients with uncomplicated obesity. Research Methods: We measured the plasma AM levels in 23 obese subjects (BMI 41.9 ± 9.8 kg/m2), 21 females and 2 males (mean age 31 ± 7.2 years), before and during a euglycemic hyperinsulinemic clamp. The control group consisted of 43 healthy subjects (HS) (22 males and 21 females; mean age 38 ± 12 years; BMI 23.3 ± 3.2 kg/m2). Results: Baseline plasma AM was found to be higher in obese subjects (20.4 ± 8.4 pg/ml) than in normal subjects (11.3 ± 0.8 pg/ml) (p < 0.001). A significant increase in the plasma AM levels was observed in obese subjects during acute hyperinsulinemia (from 20.4 ± 8.4 pg/ml at 0 min to 26 ± 8.9 pg/ml at 120 min, p < 0.02). Plasma AM concentrations were significantly correlated with insulin levels at 30 min (r = 0.44; p = 0.04) and 120 min (r = 0.40, p = 0.05) during the clamp. Discussion: In conclusion, acute hyperinsulinemia induced a significant increase in the plasma levels of AM in uncomplicated obese subjects. Hyperinsulinemia may, at least in part, regulate levels of AM in obesity, explaining the high levels of the peptide in these subjects.",
keywords = "Adrenomedullin, Euglycemic hyperinsulinemic clamp",
author = "Claudio Letizia and Gianluca Iacobellis and C. Caliumi and F. Leonetti and D. Cotesta and Ribaudo, {M. C.} and L. Petramala and R. Cianci and M. Celi and E. D'Erasruio and {Di Mario}, U.",
year = "2005",
month = "3",
day = "1",
doi = "10.1055/s-2005-837519",
language = "English",
volume = "113",
pages = "171--175",
journal = "Experimental and Clinical Endocrinology and Diabetes",
issn = "0947-7349",
publisher = "Thieme",
number = "3",

}

TY - JOUR

T1 - Acute hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity

AU - Letizia, Claudio

AU - Iacobellis, Gianluca

AU - Caliumi, C.

AU - Leonetti, F.

AU - Cotesta, D.

AU - Ribaudo, M. C.

AU - Petramala, L.

AU - Cianci, R.

AU - Celi, M.

AU - D'Erasruio, E.

AU - Di Mario, U.

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Objective: Adrenomedullin (AM) is a potent hypotensive peptide which may be implicated in the insulin regulatory system. Acute hyperinsulinemia exerts no influence on plasma AM in normal subjects while no data on obese subjects has been reported. Purpose: The aim of the study was to investigate the effect of acute hyperinsulinemia on the plasma AM concentration in patients with uncomplicated obesity. Research Methods: We measured the plasma AM levels in 23 obese subjects (BMI 41.9 ± 9.8 kg/m2), 21 females and 2 males (mean age 31 ± 7.2 years), before and during a euglycemic hyperinsulinemic clamp. The control group consisted of 43 healthy subjects (HS) (22 males and 21 females; mean age 38 ± 12 years; BMI 23.3 ± 3.2 kg/m2). Results: Baseline plasma AM was found to be higher in obese subjects (20.4 ± 8.4 pg/ml) than in normal subjects (11.3 ± 0.8 pg/ml) (p < 0.001). A significant increase in the plasma AM levels was observed in obese subjects during acute hyperinsulinemia (from 20.4 ± 8.4 pg/ml at 0 min to 26 ± 8.9 pg/ml at 120 min, p < 0.02). Plasma AM concentrations were significantly correlated with insulin levels at 30 min (r = 0.44; p = 0.04) and 120 min (r = 0.40, p = 0.05) during the clamp. Discussion: In conclusion, acute hyperinsulinemia induced a significant increase in the plasma levels of AM in uncomplicated obese subjects. Hyperinsulinemia may, at least in part, regulate levels of AM in obesity, explaining the high levels of the peptide in these subjects.

AB - Objective: Adrenomedullin (AM) is a potent hypotensive peptide which may be implicated in the insulin regulatory system. Acute hyperinsulinemia exerts no influence on plasma AM in normal subjects while no data on obese subjects has been reported. Purpose: The aim of the study was to investigate the effect of acute hyperinsulinemia on the plasma AM concentration in patients with uncomplicated obesity. Research Methods: We measured the plasma AM levels in 23 obese subjects (BMI 41.9 ± 9.8 kg/m2), 21 females and 2 males (mean age 31 ± 7.2 years), before and during a euglycemic hyperinsulinemic clamp. The control group consisted of 43 healthy subjects (HS) (22 males and 21 females; mean age 38 ± 12 years; BMI 23.3 ± 3.2 kg/m2). Results: Baseline plasma AM was found to be higher in obese subjects (20.4 ± 8.4 pg/ml) than in normal subjects (11.3 ± 0.8 pg/ml) (p < 0.001). A significant increase in the plasma AM levels was observed in obese subjects during acute hyperinsulinemia (from 20.4 ± 8.4 pg/ml at 0 min to 26 ± 8.9 pg/ml at 120 min, p < 0.02). Plasma AM concentrations were significantly correlated with insulin levels at 30 min (r = 0.44; p = 0.04) and 120 min (r = 0.40, p = 0.05) during the clamp. Discussion: In conclusion, acute hyperinsulinemia induced a significant increase in the plasma levels of AM in uncomplicated obese subjects. Hyperinsulinemia may, at least in part, regulate levels of AM in obesity, explaining the high levels of the peptide in these subjects.

KW - Adrenomedullin

KW - Euglycemic hyperinsulinemic clamp

UR - http://www.scopus.com/inward/record.url?scp=20244374418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20244374418&partnerID=8YFLogxK

U2 - 10.1055/s-2005-837519

DO - 10.1055/s-2005-837519

M3 - Article

VL - 113

SP - 171

EP - 175

JO - Experimental and Clinical Endocrinology and Diabetes

JF - Experimental and Clinical Endocrinology and Diabetes

SN - 0947-7349

IS - 3

ER -